Cargando…

Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors

Patients with chronic hepatitis C may have advanced fibrosis at first evaluation. Using the European Association for the Study of the Liver (EASL) definition (FibroScan® >9.5 kPa) for “late presenter for care” (LP), we found that 32% (169 of 527) of patients were LP. Being a LP was associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Janne Fuglsang, Hallager, Sofie, Øvrehus, Anne, Weis, Nina, Brehm Christensen, Peer, Pedersen, Court
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774505/ https://www.ncbi.nlm.nih.gov/pubmed/29367939 http://dx.doi.org/10.1093/ofid/ofx257

Ejemplares similares

Hepatitis C prevalence in Denmark in 2016—An updated estimate using multiple national registers
por: Nielsen, Stine, et al.
Publicado: (2020)

Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs
por: Søholm, Jacob, et al.
Publicado: (2020)

Incidence, prevalence and risk factors for hepatitis C in Danish prisons
por: Søholm, Jacob, et al.
Publicado: (2019)

A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project
por: Dröse, Sandra, et al.
Publicado: (2022)

Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C
por: Hansen, Janne Fuglsang, et al.
Publicado: (2019)

Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response
por: Hallager, Sofie, et al.
Publicado: (2017)

The Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort Study
por: Hallager, Sofie, et al.
Publicado: (2018)

Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C
por: Madsen, Lone Wulff, et al.
Publicado: (2022)

IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection
por: Ruhwald, Morten, et al.
Publicado: (2012)

Hepatitis C time trends in reported cases and estimates of the hidden population born before 1965, Denmark and Sweden, 1990 to 2020
por: Christensen, Peer Brehm, et al.
Publicado: (2022)

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study
por: Dalgard, Olav, et al.
Publicado: (2017)

Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study
por: Christiansen, Karen M., et al.
Publicado: (2014)

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers
por: Christensen, Peer Brehm, et al.
Publicado: (2012)

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome
por: Pedersen, Jannie, et al.
Publicado: (2013)

Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment
por: Pedersen, Martin S., et al.
Publicado: (2021)

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3
por: Rembeck, Karolina, et al.
Publicado: (2012)

Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness
por: Lundbo, Lene Fogt, et al.
Publicado: (2014)

Mortality among Patients with Cleared Hepatitis C Virus Infection Compared to the General Population: A Danish Nationwide Cohort Study
por: Omland, Lars Haukali, et al.
Publicado: (2011)

Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
por: Madsen, Lone W., et al.
Publicado: (2022)

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
por: Alsiö, Åsa, et al.
Publicado: (2012)

The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T’N’T HepC)
por: Lazarus, Jeffrey Victor, et al.
Publicado: (2020)

Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population
por: Bollerup, Signe, et al.
Publicado: (2022)

Effect of aerobic exercise training on the fat fraction of the liver in persons with chronic hepatitis B and hepatic steatosis: Trial protocol for a randomized controlled intervention trial— The FitLiver study
por: Jespersen, Sofie, et al.
Publicado: (2023)

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study
por: Hansen, Nanna, et al.
Publicado: (2011)

Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
por: Lau, Frederik Faergemann, et al.
Publicado: (2022)

Causal factors for late presentation of retinal detachment
por: Anguita, Rodrigo, et al.
Publicado: (2022)

High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
por: Villar, Livia Melo, et al.
Publicado: (2017)

Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection
por: Clausen, Louise Nygaard, et al.
Publicado: (2015)

Antiretroviral therapy adherence strategies used by patients of a large HIV clinic in Lesotho
por: Axelsson, Johanna Maria, et al.
Publicado: (2015)

Socioeconomic status in HCV infected patients – risk and prognosis
por: Omland, Lars Haukali, et al.
Publicado: (2013)

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis
por: Ydreborg, Magdalena, et al.
Publicado: (2014)

Late presentation of chronic viral hepatitis for medical care: a consensus definition
por: Mauss, Stefan, et al.
Publicado: (2017)

The effect of antimicrobial treatment on mortality associated with urinary tract disease in mink kits (Neovison vison)
por: Mundbjerg, Karin, et al.
Publicado: (2021)

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study
por: Roed, Torsten, et al.
Publicado: (2014)

Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations
por: Sølund, Christina, et al.
Publicado: (2014)

Prevalence of Multiple Chronic Conditions Among US Adults, 2018
por: Boersma, Peter, et al.
Publicado: (2020)

Late presentation of primary headache associated with sexual activity: is non-invasive angiography worthwhile?
por: Larner, A. J.
Publicado: (2006)

Late-presenting bilateral congenital diaphragmatic hernia: An extremely rare confluence of two rarities
por: James, Justin P, et al.
Publicado: (2014)

The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China
por: Huang, Dao, et al.
Publicado: (2015)

Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g5c5f2i3ueff00aqe0f4aucer6